Inhibiting the Deubiquitinase UCHL1 Reduces SARS-CoV-2 Viral Uptake by ACE2
Author:
Affiliation:
1. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, and
2. Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio
Funder
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
Publisher
American Thoracic Society
Subject
Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology
Link
https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2022-0331OC
Reference45 articles.
1. A Novel Coronavirus from Patients with Pneumonia in China, 2019
2. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
3. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
4. Cell entry mechanisms of SARS-CoV-2
5. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibition of the Cellular Deubiquitinase UCHL1 Suppresses SARS-CoV-2 Replication;American Journal of Respiratory Cell and Molecular Biology;2023-09
2. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification;Journal of Biomedical Science;2023-08-22
3. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection;Frontiers in Cellular and Infection Microbiology;2023-06-09
4. Tipping the Balance of Ubiquitination toward a Therapy for COVID-19;American Journal of Respiratory Cell and Molecular Biology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3